MAY 11, 2015 04:29 PM PDT

Does Dopamine Maintain Chronic Pain?

More than 100 million Americans are victims of chronic pain, resulting in annual costs of approximately $600 billion in medical care and lost productivity.
Dopamine may have an impact on whether or not a person continues to feel chronic pain.
When doctors tell patients that their pain is all in their head, they may not be entirely wrong. A study at the University of Texas (UT) at Dallas - funded by the university of Texas at Dallas, the National Institutes of Health and the Rita Allen Foundation - attempts to clarify the role that dopamine plays in maintaining the sense of chronic pain transmitted to the brain by nerve signals, according to a paper published in the Journal of Neuroscience and reported in by Catharine Paddock, Ph.D., in Medical News Today (http://www.medicalnewstoday.com/articles/293713.php).

On its website, the University of Texas explains that dopamine, one of the neurotransmitters playing a major role in addiction, is a chemical messenger is similar to adrenaline that affects brain processes responsible for controlling movement, emotional response and ability to experience pleasure and pain. Dopamine regulation plays an important role in mental and physical health. For instance, in diseases like Parkinson's, dopamine-transmitting neurons die, subjecting the patient to pain that can be relieved by drugs that can help the brain to produce the neurotransmitter (http://www.utexas.edu/research/asrec/dopamine.html).

The recent study showed that in chronic pain, nerve cells keep sending pain signals to the brain even in the absence of injury. Dopamine may play a key role in maintaining this chronic pain. The researchers "traced the path of pain signals between the brain and spinal cord in mice and found removing a group of dopamine-containing cells selectively reduced chronic pain," the article explained. Ted Price, senior author of the study and associate professor in behavioral and brain sciences at UT Dallas, believes that "the study reveals a new role for dopamine in helping maintain chronic pain states, and suggests: ‘This may open up new opportunities to target medicines that could reverse chronic pain.'"

According to the article, "In acute pain, when we suffer an injury, pain signals travel like electricity from the site of the injury to the spinal cord, which passes them on in the form of other chemical or electrical pulses that in turn are relayed to brain cells that distribute them throughout the brain. In people with chronic pain, their nerve cells continue to send pain signals to the brain - even in the absence of injury - but the causes of this are not known."

The brain has several pain centers. Chronic pain appears to change they way that they are activated. The study demonstrated that targeting A11 dopamine-containing cells permanently reversed chronic pain in mice while having no affect on acute pain. Prof. Price and his group did the study to take a closer look at the effect of dopamine. When using a toxin that affected A11 neurons, they discovered that acute pain signals were still normal, but chronic pain was gone. The researchers believe that their study "increases our understanding of the causes of chronic pain and the factors that contribute to it, which should eventually lead to more effective treatments," according to the article.

Prof. Price concluded, "In future studies, we would like to gain a better understanding of how stress interacts with A11. And we'd like to know more about the interaction between molecular mechanisms that promote chronic pain and dopamine."

Source: Medical News Today
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 15, 2019
Genetics & Genomics
SEP 15, 2019
Treating Psychosis by Targeting a Genetic Mutation
It may one day be possible to treat psychiatric disorders with therapy that targets genetic mutations, which was done in a recent study....
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Ketamine is not an opioid, and treats depression in a novel way
In March, the U.S. Food and Drug Administration approved ketamine nasal spray to treat depression. Ketamine has gotten a bad rep as an opioid - which it is...
SEP 15, 2019
Cell & Molecular Biology
SEP 15, 2019
Insight Into a Common Mechanism Underlying Some Neurodevelopmental Disorders
Mutations impacting a protein complex called SWI/SNF can cause a variety of problems. Now researchers know more about why....
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Can Ecstasy Treat PTSD and Depression?
Ecstasy, also known as MDMA or “molly”, is a well-known substance known to induce feelings of euphoria and bliss, followed by a notorious, depr...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
How Much Caffeine Can Trigger a Migraine?
Do you suffer from migraines? Your caffeine intake may be a trigger. Researchers from the Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women&r...
SEP 15, 2019
Neuroscience
SEP 15, 2019
New MRI scan can reveal molecular changes in the brain
MRI scans give us pictures of the brain that depict the physical structure of brain tissue. Now, researchers discovered a way to determine the biological m...
Loading Comments...